Topics
April 2014 | Editor's Message
A Bittersweet Sign Off
Rachel Renshaw, Editor-in-Chief
June 17, 2026
Bayer Completes Acquisition of Perfuse Therapeutics, Gains Full Rights to PER-001
June 15, 2026
Ethyreal Bio Presents Preclinical Data Supporting Clinical Advancement of ETHY-001 for Thyroid Eye Disease
BVI Opens Experience Hub in Spain to Expand Ophthalmic Surgical Education and Collaboration
June 12, 2026
Genetic Analysis Links Aspirin Use to Increased Risk of Early and Dry AMD
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Supported by Zeiss
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Free Print Subscription
Email Newsletter
Conference Calendar
